Explore the differences between dose constraints in External Beam Radiotherapy (EBRT) and Radiopharmaceutical Therapy (RPT) in this 55-minute invited talk by Dr. Tahir Yusufaly, Faculty Member at Johns Hopkins University Department of Radiology. Delve into the complexities of dose distribution, radiobiology, and efforts to develop universal models for Biologically Effective Dose (BED) and Normal Tissue Complication Probability (NTCP). Gain insights into the emerging field of computational nuclear oncology and its potential impact on future cancer treatments.
Dose Constraints in Radiopharmaceutical Therapy vs. External Beam Radiotherapy - Challenges and Considerations
Molecular Imaging & Therapy via YouTube
Overview
Syllabus
Introduction
Dose distribution in RPT vs. External Beam Radiotherapy EBRT
Brief overview of EBRT radiobiology
Efforts towards a more universal Biologically Effective Dose BED
Efforts towards a more universal normal tissue complication probability NTCP
Summary and future outlook computational nuclear oncology
Summary
Taught by
Molecular Imaging & Therapy
